Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5

被引:26
作者
Suenkel, Benjamin [1 ]
Valente, Sergio [2 ,3 ]
Zwergel, Clemens [2 ,3 ]
Weiss, Sandra [1 ]
Di Bello, Elisabetta [2 ,3 ]
Fioravanti, Rossella [2 ,3 ]
Aventaggiato, Michele [4 ]
Amorim, Joao A. [5 ,6 ,7 ]
Garg, Neha [7 ]
Kumar, Surinder [8 ]
Lombard, David B. [8 ,9 ]
Hu, Tuo [10 ]
Singh, Pankaj K. [10 ,11 ]
Tafani, Marco [4 ,12 ]
Palmeira, Carlos M. [5 ,6 ]
Sinclair, David [7 ]
Mai, Antonello [2 ,3 ]
Steegborn, Clemens [1 ]
机构
[1] Univ Bayreuth, Dept Biochem, D-95440 Bayreuth, Germany
[2] Sapienza Univ Rome, Dept Drug Chem & Technol, I-00185 Rome, Italy
[3] Pasteur Inst, Cenci Bolognetti Fdn, I-00185 Rome, Italy
[4] Sapienza Univ Rome, Dept Expt Med, I-00161 Rome, Italy
[5] Univ Coimbra, Dept Life Sci, Coimbra, Portugal
[6] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal
[7] Harvard Med Sch, Blavatnik Inst, Glenn Ctr Biol Aging Res, Genet Dept, Boston, MA 02115 USA
[8] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[9] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA
[10] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[11] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[12] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
SMALL-MOLECULE ACTIVATORS; 1,4-DIHYDROPYRIDINES; INHIBITION; TARGETS; RESVERATROL; COMPLEXES; MECHANISM; DISCOVERY; DESIGN;
D O I
10.1021/acs.jmedchem.2c01215
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sirtuins are NAD+-dependent protein deacylases involved in metabolic regulation and aging-related diseases. Specific activators for seven human Sirtuin isoforms would be important chemical tools and potential therapeutic drugs. Activators have been described for Sirt1 and act via a unique N-terminal domain of this isoform. For most other Sirtuin isoforms, including mitochondrial Sirt3-5, no potent and specific activators have yet been identified. We here describe the identification and character-ization of 1,4-dihydropyridine-based compounds that either act as pan Sirtuin activators or specifically stimulate Sirt3 or Sirt5. The activators bind to the Sirtuin catalytic cores independent of NAD+ and acylated peptides and stimulate turnover of peptide and protein substrates. The compounds also activate Sirt3 or Sirt5 in cellular systems regulating, e.g., apoptosis and electron transport chain. Our results provide a scaffold for potent Sirtuin activation and derivatives specific for Sirt3 and Sirt5 as an excellent basis for further drug development.
引用
收藏
页码:14015 / 14031
页数:17
相关论文
共 50 条
  • [21] SIRT5 regulation of ammonia-induced autophagy and mitophagy
    Polletta, Lucia
    Vernucci, Enza
    Carnevale, Ilaria
    Arcangeli, Tania
    Rotili, Dante
    Palmerio, Silvia
    Steegborn, Clemens
    Nowak, Theresa
    Schutkowski, Mike
    Pellegrini, Laura
    Sansone, Luigi
    Villanova, Lidia
    Runci, Alessandra
    Pucci, Bruna
    Morgante, Emanuela
    Fini, Massimo
    Mai, Antonello
    Russo, Matteo A.
    Tafani, Marco
    AUTOPHAGY, 2015, 11 (02) : 253 - 270
  • [22] Metformin Reduces Hepatic Expression of SIRT3, the Mitochondrial Deacetylase Controlling Energy Metabolism
    Buler, Marcin
    Aatsinki, Sanna-Mari
    Izzi, Valerio
    Hakkola, Jukka
    PLOS ONE, 2012, 7 (11):
  • [23] Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes
    Zhao, Hong-Cui
    Ding, Ting
    Ren, Yun
    Li, Tian-Jie
    Li, Rong
    Fan, Yong
    Yan, Jie
    Zhao, Yue
    Li, Mo
    Yu, Yang
    Qiao, Jie
    HUMAN REPRODUCTION, 2016, 31 (03) : 607 - 622
  • [24] Sirt3 binds to and deacetylates mitochondrial pyruvate carrier 1 to enhance its activity
    Liang, Lei
    Li, Qingguo
    Huang, Liyong
    Li, Dawei
    Li, Xinxiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 468 (04) : 807 - 812
  • [25] Protein Kinase C Epsilon Promotes Cerebral Ischemic Tolerance Via Modulation of Mitochondrial Sirt5
    Morris-Blanco, Kahlilia C.
    Dave, Kunjan R.
    Saul, Isabel
    Koronowski, Kevin B.
    Stradecki, Holly M.
    Perez-Pinzon, Miguel A.
    SCIENTIFIC REPORTS, 2016, 6
  • [26] NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death
    Debsharma, Subhashis
    Pramanik, Saikat
    Bindu, Samik
    Mazumder, Somnath
    Das, Troyee
    Pal, Uttam
    Saha, Debanjan
    De, Rudranil
    Nag, Shiladitya
    Banerjee, Chinmoy
    Maiti, Nakul Chandra
    Ghosh, Zhumur
    Bandyopadhyay, Uday
    ISCIENCE, 2024, 27 (04)
  • [27] Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3
    Mathieu, Lise
    Costa, Alexandra Lopes
    Le Bachelier, Carole
    Slama, Abdelhamid
    Lebre, Anne-Sophie
    Taylor, Robert W.
    Bastin, Jean
    Djouadi, Fatima
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 96 : 190 - 198
  • [28] SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy
    Qin, Zhang
    Zhou, Siyuan
    Chang, Xing
    Liu, Ruxiu
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [29] The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells
    Gurt, Irina
    Artsi, Hanna
    Cohen-Kfir, Einav
    Hamdani, Gilad
    Ben-Shalom, Gal
    Feinstein, Ben
    El-Haj, Madi
    Dresner-Pollak, Rivka
    PLOS ONE, 2015, 10 (07):
  • [30] Sirt5 Deacylation Activities Show Differential Sensitivities to Nicotinamide Inhibition
    Fischer, Frank
    Gertz, Melanie
    Suenkel, Benjamin
    Lakshminarasimhan, Mahadevan
    Schutkowski, Mike
    Steegborn, Clemens
    PLOS ONE, 2012, 7 (09):